Endocrinology

Ipsen Continues the Acquisition Process of Tercica so as to Establish Its Global Presence in Endocrinology

The Earth Times Online Newspaper (Free subscription) | yesterday

PARIS - Regulatory News: Ipsen (Paris:IPN) announced today that on 22 July 2008 it subscribed for additional shares of common stock of Tercica Inc. (NASDAQ:TRCA) and exercised in full the warrant issued by Tercica in October 2006, and converted in full the convertible

• Ipsen Continues the Acquisition Process of Tercica so as to Establish Its Global Presence in Endocrinology - Business Wire

Drug Lowers Body's 'Set Point' To Control Hyperparathyroidism In Dialysis Patients

Medical News Today (Free subscription) | 17/07/2008

A medication called cinacalcet an important part of treatment to control high levels of parathyroid hormone (PTH) in patients receiving dialysis for end-stage renal disease (ESRD) works by resetting the balance between calcium and PTH levels, according to a study in the November Journal of the American Society of Nephrology (JASN). Cinacalcet is one of a family of drugs called calcimimetics.

Doctor Contact List in the USA

Earn More Money (Free subscription) | 11/07/2008

The package below is valued at over $2000 when purchased individually Currently Practicing Doctors in the USA 788,527 in total * 17,449 emails Coverage in many different areas of medicine such as Endocrinology, Pathology, Urology, Neurology, Plastic Surgery, Psychiatry, Cardiology and much more Over a dozen sortable fields Listing of US Pharma Companies Names and email addresses of 47,000 employees...

Starvation Hormone Makes For Small Mice, Study Finds

Medical News Today (Free subscription) | 28/06/2008

Chronically high levels of a recently discovered starvation hormone markedly stunt the growth of mice, reveals a new study in the July issue of Cell Metabolism, a publication of Cell Press. The liver-produced hormone known as FGF21 does so by causing the mice to become resistant to growth hormone. "It was an unexpected finding," said David Mangelsdorf of University of Texas Southwestern Medical Center....

From the Health Desk

How I Spent My Nursing Education (Free subscription) | 23/06/2008

Another day, another specialist, another round of tests. This time: endocrinology. To be continued in two weeks…

Daily rhPTH1–84 injections could be avoided in osteoporosis treatment

Nature Publishing Group (Free subscription) | 23/06/2008

Daily rhPTH1–84 injections could be avoided in osteoporosis treatment Nature Clinical Practice Endocrinology & Metabolism 4, 364 (2008). doi:10.1038/ncpendmet0857

Pioglitazone treatment decreases BMD even in estrogen-replete women

Nature Publishing Group (Free subscription) | 23/06/2008

Pioglitazone treatment decreases BMD even in estrogen-replete women Nature Clinical Practice Endocrinology & Metabolism 4, 364 (2008). doi:10.1038/ncpendmet0858

Identification of a serum biomarker profile that could aid early diagnosis of osteoporosis

Nature Publishing Group (Free subscription) | 23/06/2008

Identification of a serum biomarker profile that could aid early diagnosis of osteoporosis Nature Clinical Practice Endocrinology & Metabolism 4, 365 (2008). doi:10.1038/ncpendmet0859

Patients with MEN1-associated ZES have a severe form of hyperparathyroidism

Nature Publishing Group (Free subscription) | 23/06/2008

Patients with MEN1-associated ZES have a severe form of hyperparathyroidism Nature Clinical Practice Endocrinology & Metabolism 4, 365 (2008). doi:10.1038/ncpendmet0860

Lipid-lowering therapy could protect against peripheral neuropathy

Nature Publishing Group (Free subscription) | 23/06/2008

Lipid-lowering therapy could protect against peripheral neuropathy Nature Clinical Practice Endocrinology & Metabolism 4, 363 (2008). doi:10.1038/ncpendmet0855

Metformin benefits low-birth-weight girls with precocious pubarche

Nature Publishing Group (Free subscription) | 23/06/2008

Metformin benefits low-birth-weight girls with precocious pubarche Nature Clinical Practice Endocrinology & Metabolism 4, 363 (2008). doi:10.1038/ncpendmet0856

CTGF might have a role in vascular and renal disease associated with type 1 diabetes

Nature Publishing Group (Free subscription) | 23/06/2008

CTGF might have a role in vascular and renal disease associated with type 1 diabetes Nature Clinical Practice Endocrinology & Metabolism 4, 363 (2008). doi:10.1038/ncpendmet0854

Growth-hormone therapy might not improve exercise capacity

Nature Publishing Group (Free subscription) | 23/06/2008

Growth-hormone therapy might not improve exercise capacity Nature Clinical Practice Endocrinology & Metabolism 4, 362 (2008). doi:10.1038/ncpendmet0853

Health risks and benefits change after withdrawal of estrogen plus progestin therapy

Nature Publishing Group (Free subscription) | 23/06/2008

Health risks and benefits change after withdrawal of estrogen plus progestin therapy Nature Clinical Practice Endocrinology & Metabolism 4, 361 (2008). doi:10.1038/ncpendmet0851

Genotype influences lipid profile and incident cardiovascular disease risk

Nature Publishing Group (Free subscription) | 23/06/2008

Genotype influences lipid profile and incident cardiovascular disease risk Nature Clinical Practice Endocrinology & Metabolism 4, 362 (2008). doi:10.1038/ncpendmet0852